Oral GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients

Cardiovascular events related to atherosclerosis are responsible for high morbidity and mortality among patients with type 2 diabetes. Improvement in care, especially in early stages, is crucial. Oral semaglutide, a glucagon-like peptide 1 analogue, controls blood glucose and results in significant...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraiva, José Francisco Kerr, Franco, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675489/
https://www.ncbi.nlm.nih.gov/pubmed/34911560
http://dx.doi.org/10.1186/s12933-021-01417-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675489/
https://www.ncbi.nlm.nih.gov/pubmed/34911560
http://dx.doi.org/10.1186/s12933-021-01417-0

Ejemplares similares